目的:观察准分子激光原位角膜磨镶术(laser epithelial keratomileusis,LASEK)术后露达舒的临床疗效。方法:对200例患者行LASEK手术,分为A组100例200眼术后点用典必殊滴眼液1wk,B组100例200眼术后点用露达舒滴眼液联合托百士滴眼液1wk,术后定期对眼部症状、视力、屈光度、角膜厚度、眼压进行随访观察。结果:A组用药后高眼压12眼(6.0%)。B组用药后高眼压3眼(1.5%)。两组对照比较P<0.05,有显著差异,点用露达舒滴眼液组眼压增高发病率明显降低。结论:露达舒在LASEK术后应用是安全有效的。

AIM: To observe the clinical effect of Lotemax on intraocular pressure(IOP) after laser epithelial keratomileusis(LASEK). METHODS: Two hundred cases after LASEK surgery were divided into group A of 100 cases (200 eyes) with postoperative Tobradex eyedrops for a week, group B of 100 cases (200 eyes) with joint eyedrops of Lotemax and Tobrex for a week. Ocular symptoms, vision,diopter, corneal thickness and IOP were observed in the follow-up. RESULTS: Group A was with high IOP in 12 eyes(6.0%). Group B with of high IOP in 3 eyes(1.5%). It was significantly different P<0.05. Lotemax eyedrops significantly reduced the incidence of increased IOP. CONCLUSION: Lotemax after LASEK surgery is safe and effective.

R779.63